Variable importance plot (mean decrease accuracy and mean decrease Gini). by Fernando Martinez-Taboada (8655132)

Modeled concentrations (mg/kg dry weight) of lead (Pb) in <i>Hylocomium splendens</i> moss tissue in 2006 and 2017, average change, percent change, and probability of decrease for 5 strata. by Peter N. Neitlich (4034300)

Modeled concentrations (mg/kg dry weight) of zinc (Zn) in <i>Hylocomium splendens</i> moss tissue in 2006 and 2017, average change, percent change, and probability of decrease for 5 strata. by Peter N. Neitlich (4034300)

Modeled concentrations (mg/kg dry weight) of cadmium (Cd) in <i>Hylocomium splendens</i> moss tissue in 2006 and 2017, average change, percent change, and probability of decrease for 5 strata. by Peter N. Neitlich (4034300)

<i>neurod1</i>^<i>ΔUCE</i> homozygous mutants display a decrease in the expression of several EE hormones. by Anne Sophie Reuter (12239993)

Decreased trigger factor association and increased DnaK association with ribosomes furthers protein homeostasis during Mg²⁺ starvation. by Carissa Chan (18310140)

Knock-down of <i>PYCR1</i> decreases proliferation of CRC cell lines. by Saif Sattar Alaqbi (12055053)

Knock-down of <i>PYCR1</i> decreases growth of CRC cell lines. by Saif Sattar Alaqbi (12055053)

Effects of H5 (20 and 40 mg/kg, p.o.), and diazepam (2.5 mg/kg, i.p.) in the Rota-rod test in mice. by Maria Alice Miranda Bezerra Medeiros (11752002)

Fig 5 - by Dalia Zaafar (6693017)

Immunohistochemical analysis of p-Akt expression in various experimental groups showing negative expression in control group, marked increased expression along the extended fibrous... by Rehab F. Abdel-Rahman (11886404)

The density of PNN in HVC is no longer decreased 4 months after treatment with ChABC. by Gilles Cornez (718394)

Medication satisfaction over 8-week study medication period. by Judith I. Tsui (5983160)

Subjects:

Medication tolerability, discontinuations, adherence over the 8-week study period. by Judith I. Tsui (5983160)

Subjects:

Main results: Changes in primary and secondary outcomes from baseline to 8 weeks in the PETER PAIN trial. by Judith I. Tsui (5983160)

Subjects:

Baseline characteristics of PETER PAIN study participants: People with HIV, chronic pain, and heavy alcohol use (n = 45). by Judith I. Tsui (5983160)

Subjects:

Adverse events in low-dose naltrexone arm. by Judith I. Tsui (5983160)

Subjects:

CONSORT flow diagram. by Judith I. Tsui (5983160)

Subjects:

Adverse events in placebo arm. by Judith I. Tsui (5983160)

Subjects:

Adverse events in gabapentin arm. by Judith I. Tsui (5983160)

Subjects: